Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
None listed
Sponsors
Dr Nishant Tyagi
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients having altered serum liver enzymes levels defined as serum AST and or ALT normal 35-40 mg dl but 2 times of upper normal limit and ultrasonographical evidence of non alcoholic fatty liver disease 2 Individuals of either sex between the age of 18 to 70 years 3 Patients willing and able to participate for 12 weeks drug 4 Patients having FIB 4 score less than 2.67
Exclusion criteria
Exclusion criteria: 1 Individuals not willing to undergo the clinical trial 2 Patients having serum liver enzymes AST and or ALT levels 2 times of upper normal limit 3 Patients having hepatitis B and or hepatitis C or having any other comorbidity 4 Patients consuming alcohol 5 History of hypersensitivity to any of the trial drug or their ingredients 6 Individuals who have completed participation in any other clinical trial during the past six months 7 Any other condition which the Principal investigator thinks may jeopardize the study 8 Patients having FIB 4 score more than 2.67
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Normalization ofliver enzymes 2) Improvement in fatty liver gradingTimepoint: At baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Improvement in lipid profile 2 reduction inserum liver enzymes Timepoint: At baseline | — |
Countries
India
Contacts
Public ContactDr Bindu Chauhan
Abhilashi Ayurvedic College and research institute chail chowk District Mandi Himachal Pradesh
Outcome results
None listed